News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anacor Pharmaceuticals, Inc. Appoints Paul L. Berns to Its Board of Directors



6/4/2012 10:56:15 AM

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today the appointment of Paul L. Berns to its Board of Directors. Since 2006, Mr. Berns has served as the President, Chief Executive Officer, and a member of the Board of Directors of Allos Therapeutics, a biopharmaceutical company focused on developing and commercializing anti-cancer therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES